| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥4.34B | +73.5% |
| Gross profit | ¥0.40B | — |
| Operating income | ¥0.20B | — |
| Net income | ¥0.20B | +538.1% |
| Gross margin | 9.1% | Net margin 4.6% |
| Revenue Q/Q | +10.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.94B | 90.9% |
| R&D | ¥0.05B | 1.2% |
| SG&A | ¥0.05B | 1.2% |
| Tax & other | ¥-0.00B | -0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
智信精密 ・ 尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies